Literature DB >> 32067014

Natural products as modulators of eukaryotic protein secretion.

Hendrik Luesch1, Ville O Paavilainen.   

Abstract

Covering: up to the end of 2019Diverse natural product small molecules have allowed critical insights into processes that govern eukaryotic cells' ability to secrete cytosolically synthesized secretory proteins into their surroundings or to insert newly synthesized integral membrane proteins into the lipid bilayer of the endoplasmic reticulum. In addition, many components of the endoplasmic reticulum, required for protein homeostasis or other processes such as lipid metabolism or maintenance of calcium homeostasis, are being investigated for their potential in modulating human disease conditions such as cancer, neurodegenerative conditions and diabetes. In this review, we cover recent findings up to the end of 2019 on natural products that influence protein secretion or impact ER protein homeostasis, and serve as powerful chemical tools to understand protein flux through the mammalian secretory pathway and as leads for the discovery of new therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32067014      PMCID: PMC7365592          DOI: 10.1039/c9np00066f

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  147 in total

1.  The marine product cephalostatin 1 activates an endoplasmic reticulum stress-specific and apoptosome-independent apoptotic signaling pathway.

Authors:  Nancy López-Antón; Anita Rudy; Nicole Barth; M Lienhard Schmitz; Lienhard M Schmitz; George R Pettit; Klaus Schulze-Osthoff; Verena M Dirsch; Angelika M Vollmar
Journal:  J Biol Chem       Date:  2006-08-31       Impact factor: 5.157

2.  Inhibition of p97-dependent protein degradation by Eeyarestatin I.

Authors:  Qiuyan Wang; Lianyun Li; Yihong Ye
Journal:  J Biol Chem       Date:  2008-01-16       Impact factor: 5.157

Review 3.  Small-Molecule Target Engagement in Cells.

Authors:  Marc Schürmann; Petra Janning; Slava Ziegler; Herbert Waldmann
Journal:  Cell Chem Biol       Date:  2016-03-31       Impact factor: 8.116

4.  Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1.

Authors:  Jürgen Besemer; Hanna Harant; Shirley Wang; Berndt Oberhauser; Katharina Marquardt; Carolyn A Foster; Erwin P Schreiner; Jan E de Vries; Christiane Dascher-Nadel; Ivan J D Lindley
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

5.  Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase.

Authors:  A Heifetz; R W Keenan; A D Elbein
Journal:  Biochemistry       Date:  1979-05-29       Impact factor: 3.162

6.  Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells.

Authors:  M Lam; G Dubyak; C W Distelhorst
Journal:  Mol Endocrinol       Date:  1993-05

7.  Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase.

Authors:  O Thastrup; P J Cullen; B K Drøbak; M R Hanley; A P Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  Decatransin, a new natural product inhibiting protein translocation at the Sec61/SecYEG translocon.

Authors:  Tina Junne; Joanne Wong; Christian Studer; Thomas Aust; Benedikt W Bauer; Martin Beibel; Bhupinder Bhullar; Robert Bruccoleri; Jürg Eichenberger; David Estoppey; Nicole Hartmann; Britta Knapp; Philipp Krastel; Nicolas Melin; Edward J Oakeley; Lukas Oberer; Ralph Riedl; Guglielmo Roma; Sven Schuierer; Frank Petersen; John A Tallarico; Tom A Rapoport; Martin Spiess; Dominic Hoepfner
Journal:  J Cell Sci       Date:  2015-01-22       Impact factor: 5.285

9.  Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts.

Authors:  Jeffrey D Serrill; Xuemei Wan; Andrew M Hau; Hyo Sang Jang; Daniel J Coleman; Arup K Indra; Adam W G Alani; Kerry L McPhail; Jane E Ishmael
Journal:  Invest New Drugs       Date:  2015-11-12       Impact factor: 3.850

10.  Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors.

Authors:  Likun Wang; B Gayani K Perera; Sanjay B Hari; Barun Bhhatarai; Bradley J Backes; Markus A Seeliger; Stephan C Schürer; Scott A Oakes; Feroz R Papa; Dustin J Maly
Journal:  Nat Chem Biol       Date:  2012-10-21       Impact factor: 15.040

View more
  14 in total

1.  Targeting and extending the eukaryotic druggable genome with natural products.

Authors:  Hendrik Luesch; John B MacMillan
Journal:  Nat Prod Rep       Date:  2020-06-24       Impact factor: 13.423

2.  Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.

Authors:  Marie O Pohl; Laura Martin-Sancho; Ranjala Ratnayake; Kris M White; Laura Riva; Qi-Yin Chen; Gauthier Lieber; Idoia Busnadiego; Xin Yin; Samuel Lin; Yuan Pu; Lars Pache; Romel Rosales; Marion Déjosez; Yiren Qin; Paul D De Jesus; Anne Beall; Sunnie Yoh; Benjamin G Hale; Thomas P Zwaka; Naoko Matsunaga; Adolfo García-Sastre; Silke Stertz; Sumit K Chanda; Hendrik Luesch
Journal:  ACS Infect Dis       Date:  2022-06-29       Impact factor: 5.578

3.  Involvement of Sec71 and Ubp2 in tunicamycin-induced ER stress response in the fission yeast.

Authors:  Merve Yemenici; Burcu Kartal Sural; Semian Karaer Uzuner; Bedia Palabiyik
Journal:  Mol Biol Rep       Date:  2022-04-26       Impact factor: 2.742

Review 4.  Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex.

Authors:  Mark Sicking; Sven Lang; Florian Bochen; Andreas Roos; Joost P H Drenth; Muhammad Zakaria; Richard Zimmermann; Maximilian Linxweiler
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

5.  Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F.

Authors:  Guanghui Zong; Zhijian Hu; Kwabena Baffour Duah; Lauren E Andrews; Jianhong Zhou; Sarah O'Keefe; Lucas Whisenhunt; Joong Sup Shim; Yuchun Du; Stephen High; Wei Q Shi
Journal:  J Org Chem       Date:  2020-12-02       Impact factor: 4.354

6.  Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor.

Authors:  Sarah O'Keefe; Peristera Roboti; Kwabena B Duah; Guanghui Zong; Hayden Schneider; Wei Q Shi; Stephen High
Journal:  J Cell Sci       Date:  2021-02-19       Impact factor: 5.285

7.  Co-translational biogenesis of lipid droplet integral membrane proteins.

Authors:  Pawel Leznicki; Hayden O Schneider; Jada V Harvey; Wei Q Shi; Stephen High
Journal:  J Cell Sci       Date:  2021-11-02       Impact factor: 5.285

8.  Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A.

Authors:  Soheila Kazemi; Shinsaku Kawaguchi; Christian E Badr; Daphne R Mattos; Ana Ruiz-Saenz; Jeffrey D Serrill; Mark M Moasser; Brian P Dolan; Ville O Paavilainen; Shinya Oishi; Kerry L McPhail; Jane E Ishmael
Journal:  Biochem Pharmacol       Date:  2020-11-03       Impact factor: 5.858

9.  Ipomoeassin-F disrupts multiple aspects of secretory protein biogenesis.

Authors:  Peristera Roboti; Sarah O'Keefe; Kwabena B Duah; Wei Q Shi; Stephen High
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

10.  Design of Coibamide A Mimetics with Improved Cellular Bioactivity.

Authors:  Takashi Kitamura; Rikito Suzuki; Shinsuke Inuki; Hiroaki Ohno; Kerry L McPhail; Shinya Oishi
Journal:  ACS Med Chem Lett       Date:  2021-12-29       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.